Skip to main content

New Star Sign throws Horoscope into disarray

The discovery of a new star sign has thrown the horoscope into disarray. Now with 13 signs, many people have changed their house, gaining traits they never imagined. At least, that's the hysteria flying round the Net. But is it true? Or is everyone worrying about nothing?


Actually, you do not change your star sign because the one you were born with is the one you will always have under the Tropical Zodiac which we have always used. In fact, there are two Zodiac charts, the Tropical and the Sidereal. The Tropical Zodiac is the one that we have always been using, so there is no need for anyone to change their sign unless they want to shift between the two systems, which have always co-existed.

The Tropical Zodiac is fixed because it is tied to the date of the Spring Equinox. This is the zodiac chart used in western astrology. The other zodiac is the Sidereal, used by astronomers and Vedic astrologers from east India. This zodiac is constantly changing and always has been changing.

So this talk about a new star sign is nothing new. In fact the Ancient Babylonians had 13 signs but wanted only 12 (for reasons of perfection) and therefore discounted the first, Ophiuchus, the Snake Holder. Where did it come from?

The US astronomer Parke Kunkle gave an interview to the Minneapolis Star Tribune, in which he claimed that due to the gravitational pull of the Moon, the star signs were one month out of orbit, meaning that the time periods for the signs of the zodiac would have to change.

The Internet did the rest. What people are not explaining is the fact that the western Tropical Zodiac has always been the same and always will be, therefore nobody has to change their star sign. In a word, hype.

Comments

Popular posts from this blog

Final lunar eclipse of 2010 set for early morning of December 21

Skygazers hoping to catch the last lunar eclipse of 2010 on Tuesday morning best be ready to stay up late (or wake up very early) to watch the full moon as it goes through a range of dramatic color changes. The December 21 lunar eclipse is expected to last about three-and-a-half hours from its start as a partial eclipse at 1:33 a.m. ET to its finish at 5:01 a.m. ET, according to NASA. The previous lunar eclipse occurred June 26 . During a lunar eclipse, the moon, the Earth, and the sun align so that the sun's rays are shielded from the moon. An eclipse of the moon can only take place if the moon is full, and only if the moon passes through some portion of Earth's shadow, which is composed of two cone-shaped parts, one nested inside the other. The start of the total eclipse is expected around 2:41 a.m, when the entire moon passes through the Earth's umbra, or inner shadow, which blocks all direct sunlight from reaching the moon. The moon will tak...

Hand, Foot and Mouth Disease (HFMD) and Onychomadesis

  Introduction Nails are underutilized as diagnostic tools, despite being involved in many dermatologic conditions. This paper explores new concepts in the treatment of median nail dystrophy (MND), onychomycosis, and the nail pathology of hand, foot, and mouth disease (HFMD). A Pubmed database literature search was conducted for MND treatment, onychomycosis treatment, and HFMD nail pathology. Only papers published after January 2008 were reviewed. The results showed that 0.1% tacrolimus ointment can be an effective treatment for MND. Early studies on laser therapy indicate that it is a safe and efficacious treatment option for onychomycosis, compared to conventional oral antifungal agents. Vicks VapoRub (The Proctor & Gamble Company, Cincinnati, OH) is effective against onychomycosis and is a reasonable option in patients who choose to forgo conventional treatments. Lastly, there is evidence to support a correlation between HFMD and onychomadesis. ...

Men With Breast Cancer Face Worse Prognosis

Men who are diagnosed with breast cancer are more likely than female patients to die in the next 15 years, researchers report. "This may be due to a difference in tumor characteristics and treatment," says study leader Hui Miao, a PhD candidate at the National University of Singapore. Male breast cancer is rare, accounting for less than 1% of all breast cancers in the U.S. Given its scarcity, few studies have assessed its prognosis "and we know of no recent studies looking at trends in survival," Miao tells WebMD. So Miao and colleagues studied 459,846 women and 2,664 men diagnosed with breast cancer in Denmark, Finland, Switzerland, Norway, Singapore, and Sweden between 1970 and 2007. Among the findings, presented at the San Antonio Breast Cancer Symposium: Men were diagnosed at an older age: 69 vs. 61 for women. Twice as many men had later stage III or IV disease: 18% vs. 9% of women. Only 25% of men were alive 15 years after diagnosis, compared with 44...